Search - tctmd.com

Displaying 381 - 400 of 502

Sort: Relevancy | Date

News Industry News

GOLD AF Registry to Capture Real-World Insights Using Medtronic Phased RF Ablation to Treat Patients with Atrial Fibrillation

April 07, 2015

News Industry News

Medtronic Initiates Trial Evaluating Cryoballoon for Early Persistent AF

February 02, 2015

News Industry News

St. Jude Medical Announces FDA Approval of FlexAbility Ablation Catheter

January 26, 2015

News Industry News

Medtronic-Sponsored European Clinical Trial to Evaluate Cryoballoon Ablation as First-Line Treatment for Patients with Symptomatic Paroxysmal Atrial Fibrillation

January 07, 2015

News Industry News

Abbott Expands Its Medical Device Business with Acquisition In Catherter-Based Electrophysiology Market

October 29, 2014

News Conference News TCT 2014

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

September 16, 2014

News Industry News

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

September 16, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation

September 16, 2014

News Industry News

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

September 13, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Conference News TCT 2014

Experts Debate Future of Renal Denervation Therapy

September 13, 2014

News Industry News

St. Jude Medical Announces CE Mark Approval and First Use of the FlexAbility Ablation Catheter

July 22, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Industry News

Cardiostim Symposium Demonstrates BIOTRONIK Home Monitoring® Advantages for Effective Management of Heart Failure Patients

June 19, 2014

News Features

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

June 18, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Industry News

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Conference News EuroPCR 2014

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Caitlin E. Cox

May 22, 2014

Advertisement

GOLD AF Registry to Capture Real-World Insights Using Medtronic Phased RF Ablation to Treat Patients with Atrial Fibrillation

Medtronic Initiates Trial Evaluating Cryoballoon for Early Persistent AF

St. Jude Medical Announces FDA Approval of FlexAbility Ablation Catheter

Medtronic-Sponsored European Clinical Trial to Evaluate Cryoballoon Ablation as First-Line Treatment for Patients with Symptomatic Paroxysmal Atrial Fibrillation

Abbott Expands Its Medical Device Business with Acquisition In Catherter-Based Electrophysiology Market

Symplicity Flex: No Benefit of Renal Denervation in Mild Resistant Hypertension

Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension

Experts Debate Future of Renal Denervation

Twelve-Month Data from St. Jude Medical EnligHTN Renal Denervation System Show Continued Safety and Efficacy for Patients

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

Experts Debate Future of Renal Denervation Therapy

St. Jude Medical Announces CE Mark Approval and First Use of the FlexAbility Ablation Catheter

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Cardiostim Symposium Demonstrates BIOTRONIK Home Monitoring® Advantages for Effective Management of Heart Failure Patients

Renal Denervation 2.0: Assessing the Failure of a Pivotal Trial

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Early Data Show Novel Catheter-Implanted Device Benefits Patients with Left Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content